Cargando…
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic virus that causes severe respiratory disease in humans with a case fatality rate close to 40%, but for which no vaccines are available. Here, we evaluated the utility of ChAdOx1, a promising replication-deficient simian aden...
Autores principales: | Munster, Vincent J., Wells, Daniel, Lambe, Teresa, Wright, Daniel, Fischer, Robert J., Bushmaker, Trenton, Saturday, Greg, van Doremalen, Neeltje, Gilbert, Sarah C., de Wit, Emmie, Warimwe, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643297/ https://www.ncbi.nlm.nih.gov/pubmed/29263883 http://dx.doi.org/10.1038/s41541-017-0029-1 |
Ejemplares similares
-
Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels
por: Adney, Danielle R., et al.
Publicado: (2014) -
SARS and MERS: recent insights into emerging coronaviruses
por: de Wit, Emmie, et al.
Publicado: (2016) -
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020) -
Domestic Pig Unlikely Reservoir for MERS-CoV
por: de Wit, Emmie, et al.
Publicado: (2017) -
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)
por: Munster, Vincent J., et al.
Publicado: (2016)